Relay Therapeutics Inc. Common Stock vs Ventas Inc. Common Stock — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.82B), while Ventas Inc. Common Stock trades at $82.53 (market cap $41.94B). The key difference: Ventas Inc. Common Stock is far larger — about 11× Relay Therapeutics Inc. Common Stock's market cap, and Ventas Inc. Common Stock pays a 2.54% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Ventas Inc. Common Stock for 0 Days on average.
| RLAY | VTR | |
|---|---|---|
Market Cap | $3.82B | $41.94B |
Volume | 4,332,079 | 4,588,793 |
Sector | Health | Real Estate |
52-Week High | $20.75 | $100.53 |
52-Week Low | $6.03 | $67.45 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.93B | $54.66B |
Dividend Yield | — | 2.54% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →Ventas is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, medical office buildings, and research-related facilities.
Read more on VTR →